Literature DB >> 7016522

Stem cell assays in the evaluation of myelotoxicity.

A Mangalik, W A Robinson.   

Abstract

The concept and characteristics of different types of hematopoietic cells have been described. Hematopoietic stem cells are currently considered to exist in a variety of populations with different degrees of commitment towards a particular cell line. By a combination of animal studies and studies with hematopoietic disorders, the concept of dividing hematopoietic stem cells into uncommitted and committed types has emerged in the past several years. Uncommitted stem cells are capable of differentiation, under the proper stimulus, into either of the cell lines of the hematopoietic system. These cells form a resting population of cells with a low mitoitic rate and a long resting (G(0)) phase. The committed stem cells are partially differentiated and mature only into one type of cell. The committed stem cell population is relatively more active than the population of uncommitted stem cells.A variety of assays both in vivo and in vitro are currently available for the study of different hematopoietic stem cells. These assays are semiquantitative. The number of colonies of mature cells which develop after the infusion or plating of a population of cells containing the stem cells is proportional to the total number of cells infused.A variety of toxic as well as biological substances have been assayed in these systems and a quantitative depression of the number of colonies produced has been noted by a variety of workers. The degree of depression in the number of colonies varies with the agent in use and the type of assay employed. These studies have demonstrated that toxicity of chemicals on the hematopoietic stem cells can be studied with these in vitro and animal studies to give an assessment of their potential toxicity in the intact organism. The recent development of the Dexter two-layer liquid culture system has provided a new impetus to the research on the uncommitted stem cell in a variety of organisms.

Entities:  

Mesh:

Year:  1981        PMID: 7016522      PMCID: PMC1568734          DOI: 10.1289/ehp.813951

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  25 in total

1.  THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA.

Authors:  J WHANG; E FREI; J H TJIO; P P CARBONE; G BRECHER
Journal:  Blood       Date:  1963-12       Impact factor: 22.113

2.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

3.  Acute toxicity of benzene inhalation to hemopoietic precursor cells.

Authors:  E M Uyeki; A E Ashkar; D W Shoeman; T U Bisel
Journal:  Toxicol Appl Pharmacol       Date:  1977-04       Impact factor: 4.219

Review 4.  Hematopoietic stem cells (third of three parts).

Authors:  P Quesenberry; L Levitt
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

5.  Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E.

Authors:  D L McLeod; M M Shreeve; A A Axelrad
Journal:  Blood       Date:  1974-10       Impact factor: 22.113

6.  Attempts at identification of hemopoietic stem cell in mouse.

Authors:  D W van Bekkum; M J van Noord; B Maat; K A Dicke
Journal:  Blood       Date:  1971-11       Impact factor: 22.113

7.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

8.  The effect of serum from patients with chronic renal failure on erythroid colony growth in vitro.

Authors:  S F Wallner; R M Vautrin; J E Kurnick; H P Ward
Journal:  J Lab Clin Med       Date:  1978-09

9.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.

Authors:  E van 't Hull; H Schellekens; B Löwenberg; M J de Vries
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.